Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Rowlands J, Cruzat V, Carlessi R, Newsholme P
Proliferation Assays Two thousand HeLa Tet-One-Puro cells were seeded in 0.5 mL of DMEM +FBS in black 96-well microplates with a transparent flat bottom
Several factors may contribute to dizziness in patients taking GLP-1 medications: Hypoglycaemia (low blood glucose) particularly when GLP-1 agonists are used alongside other glucose-lowering medications such as sulphonylureas or insulin Dehydration resulting from reduced fluid intake due to decreased appetite or from gastrointestinal side effects such as nausea, vomiting, or diarrhoea Orthostatic hypotension a drop in blood pressure upon standing, which may occur due to volume depletion or rapid weight loss Reduced caloric intake significant appetite suppression may lead to inadequate nutrition, potentially causing weakness and dizziness The frequency and severity of dizziness vary between individuals and specific GLP-1 products
AL Lpez-Lpez, HB Jaime, MDC Escobar Villanueva, MB Padilla, GV Palacios, FJA Chronic unpredictable mild stress generates oxidative stress and systemic inflammation in rats
